Eko Murmur Analysis Software (EMAS) vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Eko Murmur Analysis Software (EMAS) focuses on the early detection and differentiation of heart murmurs through auscultation data, making it suitable for initial screenings. In contrast, HeartFlow FFRct Analysis provides a non-invasive, advanced diagnostic assessment of coronary artery disease by analyzing CCTA scans to model blood flow. While both are cardiology AI tools, they address different diagnostic stages and utilize distinct data modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Eko Murmur Analysis Software (EMAS) is designed for the early detection and differentiation of heart murmurs in both adult and pediatric patients, providing clinical decision support for heart and lung disease. HeartFlow FFRct Analysis is a non-invasive diagnostic tool that aids in diagnosing coronary artery disease (CAD) by assessing blood flow in coronary arteries and guiding treatment strategies.
EMAS integrates with Eko digital stethoscopes to analyze heart sound (PCG) and optional ECG data. HeartFlow FFRct Analysis utilizes data from standard CCTA (Coronary CT Angiography) scans to create its personalized 3D models.
EMAS uses AI to analyze heart sound and ECG signals captured by digital stethoscopes to detect and characterize murmurs. HeartFlow FFRct Analysis employs AI and computational fluid dynamics (CFD) to generate personalized 3D digital models of coronary arteries from CCTA scans, analyzing blood flow and identifying areas of narrowing.
EMAS provides FDA-cleared AI for murmur detection, differentiating innocent and structural heart murmurs, and offering clinical decision support. HeartFlow FFRct Analysis generates personalized 3D digital models of coronary arteries, analyzes blood flow, identifies areas of narrowing with FFRct values, and aids in diagnosing coronary artery disease and guiding treatment strategies.
More Comparisons
Backers
Who funded each tool's parent company.